In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not

Metabolism: Clinical and Experimental

Volumn 62, Issue 3, 2013, Pages 352-360

  Younossi, Zobair M ^a,b   Otgonsuren, Munkhzul ^b   Venkatesan, Chapy ^a   Mishra, Alita ^a  

^a INOVA FAIRFAX HOSPITAL   (United States)

^b Betty and Guy Beatty Center for Integrated Research   (United States)

Author keywords

Metabolic syndrome; NAFLD; NASH

Indexed keywords

LIVER ENZYME;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC LIVER DISEASE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORTALITY; NONALCOHOLIC FATTY LIVER; OBESITY; PRIORITY JOURNAL; RISK FACTOR; WAIST HIP RATIO;

ADULT; AGED; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BLOOD GLUCOSE; CHOLESTEROL; COHORT STUDIES; FATTY LIVER; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NUTRITION SURVEYS; PROPORTIONAL HAZARDS MODELS; QUESTIONNAIRES; TRIGLYCERIDES; UNITED STATES; YOUNG ADULT;

EID: 84874109244     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2012.08.005     Document Type: Article

References (43)

1. P. Mishra, and N. Rafiq Nonalcoholic fatty liver disease. Practical management of liver disease. Younossi Z Editor: Cambridge University press: 2008:77 Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults Aliment Pharmacol Ther 34 2011 274 285
2. Z.M. Younossi, M. Stepanova, M. Afendy, Y. Fang, Y. Younossi, and H. Mir Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008 Clin Gastroenterol Hepatol 9 2011 524 530
3. J.D. Browning, L.S. Szczepaniak, R. Dobbins, P. Nuremberg, J.D. Horton, and J.C. Cohen Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity Hepatology 40 6 2004 1387 1395
4. Z.M. Younossi, A.M. Diehl, and J.P. Ong Non-alcoholic fatty liver disease: an agenda for clinical research Hepatology 35 4 2002 746 752
5. E. Bugianesi, N. Leone, E. Vanni, G. Marchesini, F. Brunello, and P. Carucci Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma Gastroenterology 123 2002 134 140
6. C.A. Matteoni, Z.M. Younossi, T. Gramlich, N. Boparai, Y.C. Liu, and A.J. McCullough Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity Gastroenterology 116 1999 1413 1419
7. L. Serfaty, and M. Lemoine Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis Diabetes Metab 34 2008 634 637
8. A. Baranova, and Z.M. Younossi The future is around the corner: noninvasive diagnosis of progressive nonalcoholic steatohepatitis Hepatology 47 2008 373 375
9. P. Angulo, J.M. Hui, G. Marchesini, E. Bugianesi, J. George, and G.C. Farrell The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD Hepatology 45 4 2007 846 854
10. S. Saadeh, Z.M. Younossi, E.M. Remer, T. Gramlich, J.P. Ong, and M. Hurley The utility of radiological imaging in nonalcoholic fatty liver disease Gastroenterology 123 2002 745 750
11. C.D. Williams, J. Stengel, M.I. Asike, D.M. Torres, J. Shaw, and M. Contreras Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study Gastroenterology 140 2011 124 131
12. N.C. Leite, G.F. Salles, A.L. Araujo, C.A. Villela-Nogueira, and C.R. Cardoso Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus Liver Int 29 2009 113 119
13. G. Marchesini, E. Bugianesi, and G. Forlani Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome Hepatology 37 2003 917 923
14. Z.M. Younossi, T. Gramlich, C. Matteoni, N. Boparai, and A. McCullough Non-alcoholic fatty liver disease in patients with type II diabetes Clin Gastroenterol Hepatol 2 3 2004 262 265
15. M. Stepanova, N. Rafiq, and Z.M. Younossi Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study Gut 59 10 2010 1410 1415 [Epub 2010 Jul 26]
16. A. Baranova, T.P. Tran, A. Birdnic, and Z.M. Younossi Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease Aliment Pharmacol Ther 33 7 2011 801 814 http://dx.doi.org/10.1111/j.1365-2036.2011.04579x
17. C. Venkatesan, and Z.M. Younossi Potential mechanisms underlying the associations between liver enzymes and risk for type 2 diabetes Hepatology 55 3 2012 968 970 http://dx.doi.org/10.1002/hep.24769
18. Z.M. Younossi, M. Stepanova, F. Negro, S. Hallaji, Y. Younossi, B. Lam, and M. Srishord Prevalence and independent predictors of lean non-alcoholic fatty liver disease: a population based data Medicine 2012 [in press]
19. M. Otgonsuren, M. Stepanova, L. Gerber, and Z.M. Younossi Anthropometric and clinical factors associated with mortality in subjects with non-alcoholic fatty liver disease Dig Dis Sciences 2012 [in press]
20. J.P. Ong, A. Pitts, and Z.M. Younossi Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease J Hepatol 49 4 2008 608 612 [Epub 2008 Jul 9]
21. W. Dunn, R. Xu, D.L. Wingard, C. Rogers, P. Angulo, and Z.M. Younossi Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study Am J Gastroenterol 103 2008 2263 2271
22. G. Calori, G. Lattuada, F. Ragogna, M.P. Garancini, P. Crosignani, and M. Villa Fatty liver index and mortality: the Cremona study in the 15th year of follow-up Hepatology 54 1 2011 145 152
23. G. Targher, G. Zoppini, and C.P. Day Risk of all-cause and cardiovascular mortality in patients with chronic liver disease Gut 60 2011 1602 1603
24. G. Musso, R. Gambino, M. Cassader, and G. Pagano Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease Ann Med 43 8 2010 617 649
25. C.E. Ruhl, and J.E. Everhart Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population Gastroenterology 136 2009 477 485
26. N. Rafiq, C. Bai, Y. Fang, M. Srishord, A. McCullough, and T. Gramlich Long-term follow-up of patients with nonalcoholic fatty liver Clin Gastroenterol Hepatol 7 2009 234 238
27. N. Chalasani, Z. Younossi, J.E. Lavine, A.M. Diehl, E.M. Brunt, and K. Cusi The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology Gastroenterology 142 7 2012 1592 1609 [Epub 2012 May 15]
28. J.L. Kuk, and C.I. Ardern Are metabolically normal but obese individuals at lower risk for all-cause mortality? Diabetes Care 32 12 2009 2297 2299 [Epub 2009 Sep 3. PubMed PMID: 19729521; PubMed Central PMCID: PMC2782994]
29. P. Manu, C. Ionescu-Tirgoviste, J. Tsang, B.A. Napolitano, M.L. Lesser, and C.U. Correll Dysmetabolic signals in "metabolically healthy" obesity Obes Res Clin Pract. 6 1 2012 e9 e20
30. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) JAMA 285 19 2001 2486 2497
31. CDC/NCHS Analytic and Reporting Guidelines: The Third National Health and Nutrition Examination Survey, NHANES III (1988-94) 1996 CDC, [Hyattsville, MD]
32. W.C. Z Chumlea, S.S. Guo, R.J. Kuczmarski, K.M. Flegal, C.L. Johnson, and S.B. Heymsfield Body composition estimates from NHANES III bioelectrical impedance data Int J Obes Relat Metab Disord 26 12 2002 1596 1609
33. US Department of Health and Human Services (DHHS), National Center for Health Statistics Third National Health and Nutrition Examination Survey, 1988-1994, NHANES III hepatic steatosis ultrasound images assessment procedures manual 2010 Centers for Disease Control and Prevention Hyattsville, MD
34. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
35. H.I. Seo, Y.K. Cho, W.Y. Lee, E.J. Rhee, K.C. Sung, and B.S. Kim Which metabolic syndrome criteria best predict the presence of non-alcoholic fatty liver disease? Diabetes Res Clin Pract 95 1 2012 19 24
36. M. Hamaguchi, N. Takeda, T. Kojima, A. Ohbora, T. Kato, and H. Sarui Identification of individuals with non-alcoholic fatty liver disease by the diagnostic criteria for the metabolic syndrome World J Gastroenterol 18 13 2012 1508 1516 [PubMed PMID: 22509083; PubMed Central PMCID: PMC3319947]
37. Z.M. Younossi, M. Stepanova, N. Rafiq, H. Makhlouf, Z. Younoszai, and R. Agrawal Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality Hepatology 53 2011 1874 1882
38. D.H. Akbar, and A.H. Kawther Non-alcoholic fatty liver disease and metabolic syndrome: what we know and what we don't know Med Sci Monit 12 1 2006 RA23 RA26
39. Gerber L, Otgonsuren M, Mishra A, Escheik C, Birerdinc A, Stepanova M, et al. Non-alcoholic fatty liver disease (NAFLD) is associated with low level of physical activity: a population based study. Aliment Pharm Ther 2011 [in press].
40. J.K. Dowman, J.W. Tomlinson, and P.N. Newsome Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis Aliment Pharmacol Ther 33 5 2011 525 540
41. J.S. Chaikelson, T.Y. Arbuckle, S. Lapidus, and D.P. Gold Measurement of lifetime alcohol consumption J Stud Alcohol 55 2 1994 133 140
42. J. Brown, H.R. Kranzler, and F.K. Del Boca Self-reports by alcohol and drug abuse inpatients: factors affecting reliability and validity Br J Addict 87 7 1992 1013 1024
43. Z.M. Younossi, and C. Venkatesan A 2012 clinical update for internists in adult nonalcoholic fatty liver disease Panminerva Med 54 1 2012 29 37 [Review]